Work

Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder

Year: 2019

Type: article

Source: Journal of Substance Abuse Treatment

DOI: 10.1016/j.jsat.2019.08.002

Authors: Elizabeth A. Evans, Caroline Yoo, David Huang, Andrew J. Saxon, Yih-Ing Hser

Institutions: University of Massachusetts Amherst, University of California, Los Angeles, VA Puget Sound Health Care System

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: Greenwall Foundation, Yale University, National Institutes of Health, Substance Abuse and Mental Health Services Administration, National Institute on Drug Abuse, Center for Substance Abuse Treatment

Awards: G1175036340, Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder, Western States Node of the National Drug Abuse Treatment Clinical Trials Network, Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE), G4567998124, The National Drug Abuse Treatment Clinical Trials Network, Clinical Trials Network: Pacific Northwest Node, G5267369030, G7289369753, Delaware Valley Node of the Clinical Trials Network, Massachusetts Justice Cooperative Opioid Innovation Network (JCOIN) Research Center, G7977067647, Clinical Trials Network: New England Node, NIDA Clinical Trials Network: New York Node - Renewal-GY24, Clinical Trials Network: Pacific Northwest Node, Western States Node of the National Drug Abuse Treatment Clinical Trials Network

OpenAlex ID: W2967830356

FWCI: 3.914

Cites: 49

Cited by: 30

Related to: 10